LENSAR Inc (LNSR) Stock Analysis & Investment Frameworks
LENSAR Inc (LNSR) stock analysis on Invetso. Review LENSAR Inc’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
LENSAR Inc Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
LENSAR Inc Key Financial Metrics
- Market Cap: $71.38M
- Revenue: $58.44M
- ROE: 10380.25%
- ROIC: -16.02%
- Dividend Yield: N/A
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
LENSAR Inc Investment Frameworks
Invetso analyzes LENSAR Inc (LNSR) across the following frameworks:
- LENSAR Inc 10Y Growth Potential
- LENSAR Inc Scenario Analysis
- LENSAR Inc Risks & Opportunities
- LENSAR Inc Economic Moat
- LENSAR Inc Business Model
- LENSAR Inc Management
- LENSAR Inc SWOT Analysis
- LENSAR Inc Porter's 5 Forces
- LENSAR Inc PESTLE Analysis
- LENSAR Inc ESG Analysis